Clinical trialHuman

Synthetic melanotropic peptide initiates erections in men with psychogenic erectile dysfunction: double-blind, placebo controlled crossover study

The Journal of urology, 1998 Aug. Wessells H, Fuciarelli K, Hansen J and 4 others.

Study type

Clinical trial

Subjects

Human participants (PubMed MeSH: Humans)

Journal

The Journal of urology

Published

1998 Aug

PubMed

PMID 9679884 ↗

Where PepCue cites this

This paper is part of the evidence base behind this profile. Citing a study is not an endorsement of the compound: papers that found no effect are indexed the same way.

Melanotan II →

Indexed under

MeSH terms assigned by the National Library of Medicine.

Abdominal MusclesAdolescentAdultAppetiteCross-Over StudiesDouble-Blind MethodErectile DysfunctionHumansInjections, SubcutaneousMaleMiddle AgedMonitoring, Ambulatory

Other papers on Melanotan II

Randomized controlled trial · 2000

Effect of an alpha-melanocyte stimulating hormone analog on penile erection and sexual desire in men with organic erectile dysfunction

Case report · 2012

Melanotan II injection resulting in systemic toxicity and rhabdomyolysis

PepCue indexes citation metadata only and does not reproduce abstracts or full text. Read the paper at the source links above. Nothing here is medical advice or a dose recommendation.

Educational and research reference only. Not medical advice, diagnosis, or dosing guidance. Flag an error on this page